Pfizer to develop clinical trial website
21 August 2009
Pfizer is entering into a collaboration with Private Access, a company specialising in privacy-enhanced search technology, to build a new online community where patients can find out about clinical trials of new drugs and where doctors, companies and researchers can search for test subjects.
"Many patients who could benefit from participation in clinical trials don't enrol in them because they are not aware that potentially relevant research is unde way or they cannot find a specific trial to meet their needs; other woprry that they will lose control of their health information," commented Freda Lewis-Hall, Pfizer's chief medical officer in a press release.
"With unprecedented collaboration among key groups, Pfizer and Private Access believe we can build the preeminent online clinical trial community to be used industry-wide to share knowledge while giving patients the confidence and control to share their health information."
The key to Private Access' technology is that allows patients to control to whom and what purpose they consent access to all, or selected areas, of their personal health information.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
